# Labrador Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/labrador-sciences

- Industry: Healthcare
- Headquarters: Tel Aviv, Israel
- Website: www.labradorhealth.com
- Total disclosed funding: $5M
- Latest round: Seed (Jun 11, 2021)
- Investors on record: 3

## About

Labrador Sciences Inc. focuses on innovative healthcare solutions, particularly in quantitative home testing technology, aimed at enhancing diagnostic processes and patient care.Labrador Sciences Inc. specializes in healthcare technology, particularly targeting home diagnostics. Founded in 2021 in Tel Aviv, Israel, the company has completed 2 deals. The company raised USD 5.00 mn in its Seed round from investors including BoxGroup, Kli Capital, and Vast Ventures, bringing the total amount raised to USD 5.00 mn.  
The founder's information is not available.The company specializes in delivering technological solutions, focusing primarily on advanced data analytics and cloud-based software applications. Their flagship offerings revolve around providing businesses with tools to streamline operations, enhance decision-making, and improve overall efficiency. These products are engineered to address specific pain points within various industries, including supply chain management, customer relationship management, and financial forecasting. The primary clientele includes mid to large-sized enterprises across sectors such as retail, logistics, and healthcare, with significant market penetration in North America and Europe. Each solution is tailored to meet the unique needs of these industries, ensuring that end-users benefit from a customizable approach to technology integration and operational enhancement.The company's revenue model is built around a subscription-based framework, allowing clients to access its suite of products for a recurring fee. This structure facilitates steady cash flow and enables customers to scale their usage based on demands. Partnerships with retail channels and direct-to-consumer sales further diversify revenue streams, highlighting a robust market presence. Flagship products are offered at various pricing tiers, which cater to different business sizes and requirements, ensuring accessibility for a wide range of customers. Revenue is generated through both long-term contracts with enterprise clients and shorter-term agreements for smaller businesses, reinforcing the company’s commitment to serving a diverse client base effectively.Labrador Sciences Inc. has future growth plans centered around its recent acquisition by Healthy.io Ltd, set to close on April 28, 2025. This acquisition aims to integrate Labrador Health's quantitative home testing technology into Healthy.io's existing products, advancing at-home kidney diagnostics. The company will focus on developing new products that enhance at-home testing capabilities. Additionally, Labrador plans to expand its market presence beyond North America and Europe to target emerging markets in Asia and South America by the end of 2026. The recent funding will support these initiatives, enabling the development of innovative solutions and facilitating market entry.

## Funding rounds

- Seed, Jun 11, 2021, $5M — Vast Ventures, BoxGroup, Kli Capital

## Investors

- Vast Ventures (https://capitalatlas.ai/funds/vast-ventures) — Seed
- BoxGroup (https://capitalatlas.ai/funds/boxgroup) — Seed
- Kli Capital (https://capitalatlas.ai/funds/kli-capital) — Seed